Severe acute respiratory syndrome: Developing a research response

被引:9
作者
La Montagne, JR [1 ]
Simonsen, L [1 ]
Taylor, RJ [1 ]
Turnbull, J [1 ]
机构
[1] NIAID, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1086/382225
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
When severe acute respiratory syndrome (SARS) first came to world attention in March 2003, it was immediately perceived to be a global threat with a pandemic potential. To help coordinate international research efforts, the National Institute of Allergy and Infectious Diseases convened a colloquium entitled SARS: Developing a Research Response on 30 May 2003. Breakout sessions intended to identify unmet research needs in 5 areas of SARS research-clinical research, epidemiology, diagnostics, therapeutics, and vaccines-are summarized here. Since this meeting, however, the identified research needs have been only partially met. Needs that have yet to be realized include reliable methods for early identification of individuals with SARS, a full description of SARS pathogenesis and immune response, and animal models that faithfully mimic SARS respiratory symptoms. It is also of the utmost importance that the global scientific community enhance mechanisms for international cooperation and planning for SARS research, as well as for other emerging infectious disease threats that are certain to arise in the future.
引用
收藏
页码:634 / 641
页数:8
相关论文
共 25 条
[1]  
Avendano M, 2003, CAN MED ASSOC J, V168, P1649
[2]  
*CDCP, SEV AC RESP SYNDR SA
[3]   Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong [J].
Donnelly, CA ;
Ghani, AC ;
Leung, GM ;
Hedley, AJ ;
Fraser, C ;
Riley, S ;
Abu-Raddad, LJ ;
Ho, LM ;
Thach, TQ ;
Chau, P ;
Chan, KP ;
Lam, TH ;
Tse, LY ;
Tsang, T ;
Liu, SH ;
Kong, JHB ;
Lau, EMC ;
Ferguson, NM ;
Anderson, RM .
LANCET, 2003, 361 (9371) :1761-1766
[4]  
HOLMES KV, 2001, FIELDS VIROLOGY, V1, P1075
[5]  
Hsu LY, 2003, EMERG INFECT DIS, V9, P713
[6]   A major outbreak of severe acute respiratory syndrome in Hong Kong [J].
Lee, N ;
Hui, D ;
Wu, A ;
Chan, P ;
Cameron, P ;
Joynt, GM ;
Ahuja, A ;
Yung, MY ;
Leung, CB ;
To, KF ;
Lui, SF ;
Szeto, CC ;
Chung, S ;
Sung, JJY .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :1986-1994
[7]   SARS-coronavirus replicates in mononuclear cells of peripheral blood (PBMCs) from SARS patients [J].
Li, LJ ;
Wo, J ;
Shao, JB ;
Zhu, HH ;
Wu, NP ;
Li, MW ;
Yao, HP ;
Hu, MJ ;
Dennin, RH .
JOURNAL OF CLINICAL VIROLOGY, 2003, 28 (03) :239-244
[8]   Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus [J].
Li, WH ;
Moore, MJ ;
Vasilieva, N ;
Sui, JH ;
Wong, SK ;
Berne, MA ;
Somasundaran, M ;
Sullivan, JL ;
Luzuriaga, K ;
Greenough, TC ;
Choe, H ;
Farzan, M .
NATURE, 2003, 426 (6965) :450-454
[9]   Surveillance of community-acquired viral infections due respiratory viruses in Rhone-Alpes (France) during winter 1994 to 1995 [J].
Lina, B ;
Valette, M ;
Foray, S ;
Luciani, J ;
Stagnara, J ;
See, DM ;
Aymard, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1996, 34 (12) :3007-3011
[10]   Transmission dynamics and control of severe acute respiratory syndrome [J].
Lipsitch, M ;
Cohen, T ;
Cooper, B ;
Robins, JM ;
Ma, S ;
James, L ;
Gopalakrishna, G ;
Chew, SK ;
Tan, CC ;
Samore, MH ;
Fisman, D ;
Murray, M .
SCIENCE, 2003, 300 (5627) :1966-1970